The World Health Organisation (WHO) has revealed that COVID-19 infections in Africa had reduced by more than 20 percent, stating that it was the sharpest seven-day drop in two months, as the third wave pandemic relaxes.
However, the global health body, noticed that the rate of deceleration was slower than the previous waves due to the impact of more transmissible variants.
Consequently, the WHO stated that it was spearheading critical work and aiding countries in scaling up pathogen surveillance through genome sequencing to discover and respond effectively to COVID-19 variants.
WHO Regional Director for Africa, Matshidiso Moeti, who said this during a virtual press conference organized by APO Group, yesterday, noted that although the COVID-19 cases have reduced appreciably, the downward trend was frustratingly slow as a result of the lingering effects of the more infectious Delta variant.
Moeti stated that in the week that ended September 5, the continent detected more than 165,000 cases, a 23 percent reduction from the previous week, noting that the decrease was still greater than the weekly instances recorded at the top of the first wave.
According to Moeti, the more infectious Delta variant that partly fuelled the third wave has been prevailing in several countries that experienced COVID-19 surge.
“In southern Africa, for instance, where more than 4,000 COVID-19 genome sequencing data was produced in August, the Delta variant was detected in over 70 per cent of samples from Botswana, Malawi and South Africa, and in over 90 per cent from Zimbabwe. In collaboration with the South African National Bioinformatics Institute, WHO is at the forefront of the efforts to set up the Regional Centre of Excellence for Genomic Surveillance and Bioinformatics in Cape Town. The centre will support 14 countries before being expanded to serve more countries. Last year, WHO and partners established a COVID-19 sequencing laboratory network in Africa, which has to date produced nearly 40 000 sequencing data,” she said.
Moeti, who was joined by Prof. Alan Christoffels, Director of the South African National Bioinformatics Institute, and Dr Christian Happi, Prof. of Molecular Biology and Genomics and Director at the African Centre of Excellence for Genomics of Infectious Diseases at Redeemer’s University in Nigeria, bewailed that the continent lags far behind the rest of the world when it comes to sequencing, with only one per cent of over three million COVID-19 sequences conducted worldwide occurring in Africa.
She added: “The third wave has shown us how variants can hijack the efforts to tame the pandemic. Countries must step up surveillance because, without genomic information, variants can spread undetected. You can’t fix what you don’t measure. WHO has also recently provided financial support to countries including Eswatini, Sao Tome and Principe and Senegal to reinforce genomic surveillance. To date, the dominant Delta variant has been detected in 31 African countries, while the Alpha and Beta variants have respectively been identified in 44 and 39 countries.”
“The C.1.2 variant initially identified in South Africa has so far been detected in 130 cases in 10 countries globally, including five in Africa. Although the variant has exhibited concerning mutations, there is no evidence that it is more transmissible or may affect vaccine efficacy, but more research is needed.
“As Africa’s third COVID-19 pandemic wave eases off, vaccine shipments to the continent continue to grow, with around 5.5 million doses received through COVAX in the first week of September. However, only around three per cent of the continent’s population is fully vaccinated.
“To ultimately tip the scales against this pandemic, our best efforts to reduce transmission through public health measures must be met by a significant step-up in vaccine supplies and vaccinations.”